Group One Trading’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50,517
Closed -$63K 8966
2022
Q1
$63K Buy
50,517
+6,503
+15% +$7.08K ﹤0.01% 5930
2021
Q4
$51K Sell
44,014
-17,600
-29% -$26.2K ﹤0.01% 6337
2021
Q3
$118K Buy
61,614
+41,939
+213% +$82.5K ﹤0.01% 5752
2021
Q2
$46K Buy
19,675
+14,760
+300% +$35.6K ﹤0.01% 6664
2021
Q1
$13K Sell
4,915
-2,866
-37% -$8.48K ﹤0.01% 6957
2020
Q4
$19K Sell
7,781
-6,486
-45% -$14.8K ﹤0.01% 5560
2020
Q3
$33K Buy
+14,267
New +$37.4K ﹤0.01% 4897
2019
Q2
Sell
-33
Closed -$172 5726
2019
Q1
$0 Hold
33
﹤0.01% 5710
2018
Q4
$0 Hold
33
﹤0.01% 5780
2018
Q3
$0 Hold
33
﹤0.01% 5896
2018
Q2
$0 Buy
+33
New +$247 ﹤0.01% 5722

Other funds holding GNCA

Group One Trading's GNCA Position: Q2 2022 in Review

Group One Trading sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 50,517 shares — an estimated $63K sold.

Group One Trading first reported a position in GNCA in Q2 2018 and held it in 11 quarters. The position peaked at $118K in Q3 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

  • Group One Trading reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 50,517 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $63K.
  • Group One Trading first reported a position in Genocea Biosciences, Inc. in Q2 2018 and held it in 11 quarters.
  • Group One Trading's Genocea Biosciences, Inc. position peaked at $118K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.